Moderna begins testing of its COVID-19 vaccine in children 16-Mar-2021 By Jane Byrne US biotech, Moderna, reports today that the first participants have been dosed in its Phase 2/3 clinical trial investigating the efficacy of its COVID-19 vaccine in children ages 6 months to less than 12 years.